A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular Carcinoma
- 31 July 2011
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 141 (1), 141-149
- https://doi.org/10.1053/j.gastro.2011.03.045
Abstract
No abstract availableKeywords
Funding Information
- University of Connecticut Health Center (M01RR-06192)
- Massachusetts General Hospital (M01RR-01066)
- Harvard Clinical and Translational Science Center (1 UL1 RR025758-01)
- University of Colorado Denver, School of Medicine (M01RR-00051, 1 UL1 RR 025780-01)
- University of California–Irvine (M01RR-00827)
- University of Texas Southwestern Medical Center (M01RR-00633)
- North and Central Texas Clinical and Translational Science Initiative (1 UL1 RR024982-01)
- University of Southern California (M01RR-00043)
- University of Michigan Medical Center (M01RR-00042)
- Michigan Center for Clinical and Health Research (1 UL1 RR024986)
- Virginia Commonwealth University Health System (M01RR-00065)
This publication has 41 references indexed in Scilit:
- Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patientsLiver International, 2009
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Molecular targeted therapies in hepatocellular carcinomaHepatology, 2008
- A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and OutcomeClinical Cancer Research, 2008
- The EGF receptor is required for efficient liver regenerationProceedings of the National Academy of Sciences of the United States of America, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosisHepatology, 2005
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995